Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lekfarm is a leading Belarusian pharmaceutical company specializing in the development and manufacture of high-quality generic medicines. Founded in 2004 and based in Logoysk, the company operates advanced production facilities that comply with international Good Manufacturing Practice (GMP) standards. Its extensive product portfolio includes over 150 medications across key therapeutic areas such as cardiology, neurology, gastroenterology, and musculoskeletal health. Lekfarm employs a full-cycle production model, encompassing everything from pharmaceutical research and development to large-scale manufacturing and distribution. The company is a major supplier to the Belarusian healthcare system and maintains a significant export presence throughout the CIS region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lekfarm.